Title |
Cost-Effectiveness of Empagliflozin in Combination with Standard Care versus Standard Care Only in the Treatment of Heart Failure Patients in Finland
|
---|---|
Published in |
ClinicoEconomics and Outcomes Research: CEOR, January 2023
|
DOI | 10.2147/ceor.s391455 |
Pubmed ID | |
Authors |
Taru Hallinen, Santtu Kivelä, Erkki Soini, Veli-Pekka Harjola, Mari Pesonen |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Finland | 1 | 50% |
United Kingdom | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 50% |
Members of the public | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 19 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Unspecified | 5 | 26% |
Student > Bachelor | 2 | 11% |
Researcher | 1 | 5% |
Student > Postgraduate | 1 | 5% |
Student > Master | 1 | 5% |
Other | 0 | 0% |
Unknown | 9 | 47% |
Readers by discipline | Count | As % |
---|---|---|
Unspecified | 5 | 26% |
Nursing and Health Professions | 2 | 11% |
Mathematics | 1 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 5% |
Business, Management and Accounting | 1 | 5% |
Other | 1 | 5% |
Unknown | 8 | 42% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 January 2023.
All research outputs
#20,727,202
of 25,462,162 outputs
Outputs from ClinicoEconomics and Outcomes Research: CEOR
#445
of 525 outputs
Outputs of similar age
#352,274
of 476,345 outputs
Outputs of similar age from ClinicoEconomics and Outcomes Research: CEOR
#5
of 6 outputs
Altmetric has tracked 25,462,162 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 525 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.0. This one is in the 7th percentile – i.e., 7% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 476,345 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one.